Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Procko

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Chemical Biology|January 20, 2022
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2022
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactionsMagnus S Bauer, Sophia Gruber, Adina Hausch, et al.
Cell|June 21, 2014
A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cellsErik Procko, Geoffrey Y Berguig, Betty W Shen, et al.
Molecular Therapy. Methods & Clinical Development|August 26, 2024
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylationSavanna Skeeters, Kamal Bagale, Galina Stepanyuk, et al.
Elife|November 3, 2016
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancerStephanie Berger, Erik Procko, Daciana Margineantu, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Chemical Biology|January 20, 2022
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2022
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactionsMagnus S Bauer, Sophia Gruber, Adina Hausch, et al.
Cell|June 21, 2014
A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cellsErik Procko, Geoffrey Y Berguig, Betty W Shen, et al.
Molecular Therapy. Methods & Clinical Development|August 26, 2024
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylationSavanna Skeeters, Kamal Bagale, Galina Stepanyuk, et al.
Elife|November 3, 2016
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancerStephanie Berger, Erik Procko, Daciana Margineantu, et al.
Pageof 6